Health Invest Partners Ab has filed its 13F form on April 25, 2024 for Q1 2024 where it was disclosed a total value porftolio of $161 Million distributed in 44 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merck & Co., Inc. with a value of $17.6M, Eli Lilly & CO with a value of $16.2M, Unitedhealth Group Inc with a value of $11.4M, Thermo Fisher Scientific Inc. with a value of $8.83M, and Neurocrine Biosciences Inc with a value of $6M.

Examining the 13F form we can see an increase of $35M in the current position value, from $126M to 161M.

Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.

Portfolio value $161 Million
Healthcare: $161 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 44
  • Current Value $161 Million
  • Prior Value $126 Million
  • Filing
  • Period Q1 2024
  • Filing Date April 25, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 5 stocks
  • Additional Purchases 29 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.